Thursday, July 05, 2007 8:47:14 AM
Thursday July 5, 8:00 am ET
EDEN PRAIRIE, Minn., July 5, 2007 (PRIME NEWSWIRE) -- NVE Corporation (NasdaqCM:NVEC - News) today announced that the United States District Court for the District of Minnesota has dismissed with prejudice the consolidated shareholder class action lawsuit filed in 2006 against NVE and certain of its current and former executive officers and directors.
``The court order to dismiss supports our long-standing position that the lawsuits were wholly without merit,'' said NVE President and Chief Executive Officer Daniel A. Baker, Ph.D.
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that many experts believe represents the next generation of microelectronics. NVE licenses its MRAM intellectual property and sells spintronic products, including sensors and couplers, to revolutionize data sensing and transmission.
The NVE Corporation logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3120
Statements used in this press release that relate to future plans or events are forward-looking statements that are subject to certain risks and uncertainties including, among others, risks of a successful appeal of the judgment dismissing the securities action as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10 K and other reports filed with the SEC.
Contact:
NVE Corporation
Curt A. Reynders, Chief Financial Officer
(952) 829-9217
Source: NVE Corporation
Recent NVEC News
- NVE Schedules Conference Call on Fourth-Quarter and Fiscal Year Results • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:05:16 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 04:26:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:24:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 10:20:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/24/2024 03:17:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/17/2024 09:11:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:08:54 PM
- NVE Schedules Conference Call on Third-Quarter Results • GlobeNewswire Inc. • 01/10/2024 09:05:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/03/2024 09:05:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/18/2023 08:10:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:05:37 PM
- NVE Schedules Conference Call on Second-Quarter Results • GlobeNewswire Inc. • 10/11/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 09:17:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 09:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 08:57:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2023 08:50:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:45:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/19/2023 08:10:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:02:49 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/19/2023 08:02:18 PM
- NVE Schedules Conference Call on First-Quarter Results • GlobeNewswire Inc. • 07/12/2023 08:05:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM